Neuroimmune abnormalities may play a key role in fibromyalgia
· Medical Xpressedited by Lisa Lock, reviewed by Andrew Zinin
Lisa Lock
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Lead Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Fibromyalgia is a complex disorder characterized primarily by chronic widespread pain, fatigue and other physical and cognitive symptoms. Although it affects millions of people worldwide, the underlying biological mechanisms are not yet fully understood. Now, a study by the University of Barcelona suggests that neuroimmune alterations in the central nervous system may play a key role in the development and progression of this condition.
The findings, based on a comprehensive review of recent research in this field, help move beyond the view of fibromyalgia as a purely subjective condition and may open up new avenues for the diagnosis and treatment of this disorder.
"These findings converge on brain networks involved in pain processing, emotional regulation, cognition and behavior. Together, they contribute to advancing a more integrated and accurate understanding of the disorder, consistent with a biopsychosocial perspective on health, which views the condition as the result of the interaction between biological, psychological and social factors," states Marçal Castán, from the Department of Clinical Psychology and Psychobiology of the UB's Faculty of Psychology and the Service of Psychological Care of the UB, and Adela Fusté, from the same department and member of the Institute of Neurosciences at the UB (UBneuro). Both are authors of the article, published online in the journal Brain, Behavior, and Immunity.
In this regard, the researchers emphasize that, if the central nervous system and the immune system influence one another and work in an interconnected manner, factors such as sleep, stress, physical activity, lifestyle habits and psychological well-being should not be viewed "as complementary elements in the medical treatment of fibromyalgia, but as central aspects of its management."
Biological clues to a complex disorder
The study combined neuroimaging and gene expression studies, cerebrospinal fluid analysis and cellular studies—an approach that made it possible to identify a consistent pattern of neuroimmune alterations, that is, changes in the way the nervous system and the immune system communicate and regulate each other.
Among the mechanisms identified, a possible activation of the brain's immune cells—particularly microglia—stands out. Changes in the levels of cytokines and other immune molecules in the cerebrospinal fluid of patients with fibromyalgia have also been reported, as well as alterations in the expression of genes related to inflammatory processes.
"Taken together, these findings suggest a pattern of neuroimmune dysregulation that goes beyond classic inflammation and involves both mechanisms that promote inflammation and alterations in the mechanisms that regulate it," say Castán and Fusté.
Challenges in diagnosis and treatment
The study's findings could steer research toward the development of more objective biomarkers that, in the future, may help improve diagnosis—currently based on clinical criteria—or identify subgroups of patients with distinct biological profiles.
From a therapeutic perspective, these findings open the door to exploring interventions targeting the neuroimmune processes involved in pain, fatigue, mood and other symptoms, through both pharmacological strategies and a multidisciplinary approach. However, the authors emphasize that further studies—particularly longitudinal and translational ones—are needed to confirm the role of these processes and to understand how they evolve over time.
Publication details
Marçal Castán-Sogas et al, Evidence of central neuroimmune alterations in fibromyalgia: a systematic review of case-control studies, Brain, Behavior, and Immunity (2026). DOI: 10.1016/j.bbi.2026.106773
Journal information: Brain, Behavior, and Immunity
Key medical concepts
FibromyalgiaMicrogliaCytokinesGene Expression Profiling
Clinical categories
NeurologyAllergy and immunologyPsychology & Mental healthCommon illnesses & Prevention Provided by University of Barcelona Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Neuroimmune abnormalities may play a key role in fibromyalgia (2026, June 21) retrieved 21 June 2026 from https://medicalxpress.com/news/2026-06-neuroimmune-abnormalities-play-key-role.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.